Does Nycomed have a corporate social responsibility (CSR) scheme?
We run a number of CSR programmes at community level in response to local needs. Our most common activity is the provision of donations and sponsorship of charities and other organisations, including schools, orphanages, victim groups of natural disasters and healthcare-related charities.

What kinds of product does Nycomed provide?
We provide medicines and products to hospitals, specialists and general practitioners, as well as pharmacy medicines in selected markets. Read more about our products.

What are Nycomed's main markets?
Nycomed is a European-based company, which works throughout the world. As well as Europe, we have activities in fast-growing markets such as Russia/CIS, Latin America and Asia-Pacific.

What is Nycomed's fastest growing market?
Russia/CIS is Nycomed’s fastest growing market.

Does Nycomed develop new products?
New products are constantly being licensed by Nycomed. With our local understanding, product development skills and marketing expertise, Nycomed works in partnership with research companies to provide quality medicines that meet local needs in Europe. We also have our own research capacity and have an extensive pipeline.

In what way does Nycomed work with its partner companies?
In-licensing is a key part of our strategy. We value partnership and build them by being open from the start. We offer to our partners:

• Clinical trials
• Intellectual property applications and defence
• Product registration compliance, submission and support
• Pricing and reimbursement
• Quality assurance
• Advisory boards
• Line extensions that increase compliance and convenience for patients and medical professionals.

How many people work at Nycomed?
Nycomed has approximately 12,000 employees.

Is Nycomed planning to be listed on the stock exchange?
Nycomed is owned by a consortium of private equity companies. It's our owners decision if, how and when to exit.